As reported on PharmaTimes, Merz Therapeutics has announced the completion of participant enrollment in two international Phase 3 clinical trials investigating XEOMIN (incobotulinumtoxinA) as a potential preventive treatment for both…
AML is an aggressive cancer of the blood and bone marrow, that sometimes moves so quickly, that treatment cannot conquer it. Car-T cell therapy has been incredibly successful in B-cell…
Editor's Note: This article was written and submitted to us by Victoria Barghout, CEO and Founder Viver Health. Sixteen years ago, I was diagnosed with breast cancer the day before…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
